United States - English - NLM (National Library of Medicine)

patterson dental supply, inc. - mepivacaine hydrochloride (unii: 4vfx2l7em5) (mepivacaine - unii:b6e06qe59j) - mepivacaine hydrochloride 20 mg in 1 ml - mepivacaine is indicated for production of local anesthesia for dental procedures by infiltration or nerve block in adults and pediatric patients. mepivacaine is contraindicated in patients with a known hypersensitivity to amide-type local anesthetics.

United States - English - NLM (National Library of Medicine)

novocol pharmaceutical of canada, inc. - mepivacaine hydrochloride (unii: 4vfx2l7em5) (mepivacaine - unii:b6e06qe59j) - mepivacaine hydrochloride 30 mg in 1 ml - mepivacaine is indicated for production of local anesthesia for dental procedures by infiltration or nerve block in adults and pediatric patients. mepivacaine is contraindicated in patients with a known hypersensitivity to amide-type local anesthetics.

United States - English - NLM (National Library of Medicine)

septodont, inc. - mepivacaine hydrochloride (unii: 4vfx2l7em5) (mepivacaine - unii:b6e06qe59j) - mepivacaine hydrochloride 30 mg in 1 ml - mepivacaine is indicated for production of local anesthesia for dental procedures by infiltration or nerve block in adults and pediatric patients. scandonest is contraindicated in patients with a known hypersensitivity to amide-type local anesthetics.

United States - English - NLM (National Library of Medicine)

septodont, inc. - mepivacaine hydrochloride (unii: 4vfx2l7em5) (mepivacaine - unii:b6e06qe59j) - carbocaine is indicated for production of local anesthesia for dental procedures by infiltration or nerve block in adults and pediatric patients. carbocaine is contraindicated in patients with a known hypersensitivity to amide-type local anesthetics.

United States - English - NLM (National Library of Medicine)

ndc, inc. - mepivacaine hydrochloride (unii: 4vfx2l7em5) (mepivacaine - unii:b6e06qe59j) - mepivacaine hydrochloride 30 mg in 1 ml - mepivacaine is indicated for production of local anesthesia for dental procedures by infiltration or nerve block in adults and pediatric patients. mepivacaine is contraindicated in patients with a known hypersensitivity to amide-type local anesthetics.

United States - English - NLM (National Library of Medicine)

novocol pharmaceutical of canada, inc. - mepivacaine hydrochloride (unii: 4vfx2l7em5) (mepivacaine - unii:b6e06qe59j) - mepivacaine hydrochloride 30 mg in 1 ml - mepivacaine is indicated for production of local anesthesia for dental procedures by infiltration or nerve block in adults and pediatric patients. mepivacaine is contraindicated in patients with a known hypersensitivity to amide-type local anesthetics.

United States - English - NLM (National Library of Medicine)

pearson dental - mepivacaine hydrochloride (unii: 4vfx2l7em5) (mepivacaine - unii:b6e06qe59j) - mepivacaine hydrochloride 30 mg in 1 ml - mepivacaine is indicated for production of local anesthesia for dental procedures by infiltration or nerve block in adults and pediatric patients. mepivacaine is contraindicated in patients with a known hypersensitivity to amide-type local anesthetics.

United States - English - NLM (National Library of Medicine)

iq dental - mepivacaine hydrochloride (unii: 4vfx2l7em5) (mepivacaine - unii:b6e06qe59j) - mepivacaine hydrochloride 30 mg in 1 ml - mepivacaine is indicated for production of local anesthesia for dental procedures by infiltration or nerve block in adults and pediatric patients. mepivacaine is contraindicated in patients with a known hypersensitivity to amide-type local anesthetics.

European Union - English - EMA (European Medicines Agency)

mylan s.a.s. - rasagiline tartrate - parkinson disease - anti-parkinson drugs - rasagiline mylan is indicated for the treatment of idiopathic parkinson’s disease (pd) as monotherapy (without levodopa) or as adjunct therapy (with levodopa) in patients with end of dose fluctuations.

European Union - English - EMA (European Medicines Agency)

zentiva k.s. - efavirenz, emtricitabine, tenofovir disoproxil, phosphate - hiv infections - antivirals for systemic use, - efavirenz/emtricitabine/tenofovir disoproxil zentiva is a fixed-dose combination of efavirenz, emtricitabine and tenofovir disoproxil. it is indicated for the treatment of human immunodeficiency virus-1 (hiv-1) infection in adults aged 18 years and over with virologic suppression to hiv-1 rna levels of < 50 copies/ml on their current combination antiretroviral therapy for more than three months. patients must not have experienced virological failure on any prior antiretroviral therapy and must be known not to have harboured virus strains with mutations conferring significant resistance to any of the three components contained in efavirenz/emtricitabine/tenofovir disoproxil zentiva prior to initiation of their first antiretroviral treatment regimen., the demonstration of the benefit of the combination efavirenz/emtricitabine/tenofovir disoproxil is primarily based on 48-week data from a clinical study in which patients with stable virologic suppression on a combination antiretroviral therapy changed to efavir